Vecata
VC Fund
Vejle, Denmark
Vecata is a VC fund in Vejle focused on Biotechnology and Credit. Vecata Invest A/S is an investment company managing the Bagger-Sorensen Group’s direct investments in operative companies. Vecata Invest A/S do not focus on specific industries.The investments are made direct in relevant portfolio companies and Vecata Invest A/S participates actively in the development of these. The company doesnot invest in the funds-of-funds segment.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Vecata invests in
Stages Vecata invests in
Countries Vecata invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series B
- $8M–$14M
Investment Focus
Industry
- Biotechnology 2 (67%)
- Credit 1 (33%)
- Finance 1 (33%)
- Health Care 1 (33%)
- Marketplace 1 (33%)
Stage
- Series B 2 (67%)
- Pre-Seed 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Birgith Rask Jensen
P.A. in Vecata
|
P.A. in Vecata | Total investments: 0 | Find email | |
| CEO | Total investments: 0 | Find email | ||
|
Jennifer Fode
P.A.
|
P.A. | Total investments: 0 | Find email | |
|
John Riis Mortensen
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
|
Steen Bagger-Sorensen
Investment Director
|
Investment Director | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Flex Funding A/S is the first crowdfunding company authorized as a payment institution by the Danish FSA. Authorization means that management at all times must be Fit & Proper-approved, as required, and that the company must meet certain capital requirements and end requirements for IT security. We are basically an online auction for moneywhere private people lend money directly to businesses. We connect companies that seek capital, with private lenders who have money in their deposit account. There is no middlemen, no banks and no hidden fees. It is a much better business for everyone.Create easily and quickly an account here and get started lending money to businesses or apply for a corporate loan. As a lender, you must deposit money into your Flex Funding account before you can bid. As a company, you can quickly create your account and apply for loans. | Pre-Seed / Dec 01, 2017 | ||
| Fluxome is a global supplier of natural ingredients with beneficial effects to the human health. They believe that their unique technology and their focused efforts towards developing safe and natural nutraceutical ingredients from a secure and renewable source can help make a difference for their customers. | $14.3M / Series B / Jul 23, 2008 | ||
| LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -> LiPlaCis®, Oxaliplatin -> LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects. | $8M / Series B / Mar 01, 2005 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Vecata invest in?
Vecata invests primarily in Biotechnology, Credit and Finance startups, most often at Series B and Pre-Seed stage. Most of the 3 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Vecata invest in?
Vecata typically joins rounds of $8M–$14M at Series B. These are whole funding-round sizes, not Vecata's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Vecata took part in.
How do I contact Vecata?
Public channels for Vecata include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Vecata?
The team at Vecata includes Birgith Rask Jensen (P.A. in Vecata), Hans-Henrik Eriksen (CEO) and Jennifer Fode (P.A.). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!